We enjoy getting to know the people behind clinical trials in every aspect. It takes collaboration and innovation to make the industry succeed. We stopped at the Opus Regulatory Inc. Booth at #dia2022 to talk with Allison and Victoria about what they do at the firm. #cenexel
We enjoy meeting people, like Patrick, Director at DataCore at NYU Langone Health, behind the research at event shows like #dia2022 in Chicago happening now. We thank all researchers & data managers for your hard work helping clinical trials succeed. We appreciate you! #cenexel
Rockstars like Carol Minoughan, Director of Business Development at CenExel JBR in SLC, UT, and CenExel FCR in Tampa, FL, along with Patrick McLaughlin, CEO, CenExel ACT, in Anaheim, CA, make talking about all that CenExel offers partners seem effortless.
.
.
.
#cenexel#dia2022
We have an awesome marketing and events team at CenExel. Dave Blackmer, Director of Marketing and Melanie Mestas, Events Manager, have been tirelessly sharing clinical trial information with #DIA2022 event guests, curious about who we are & what we offer patients & sponsors.
.@CenExel announces the acquisition of Apex Innovative Sciences!
The acquisition elevates CenExel to be the most prolific wholly-owned neuroscience research site network in the world. #BioHive
https://t.co/0vSto55H2i
CenExel Conversations: Live at #DIA2022 w/@CISCRP celebrating Innovation & Collaboration.
“. . . We recognize & appreciate the unprecedented gift of participation in clinical trials; enhance & enrich the participation experience for patients & their families. . .” #cenexel
Innovation and collaboration in clinical research at #DIA2022 is everywhere. The team from @Phlexglobal, leverages dedicated and authoritative TMF technologies and expert services to bring order, stability, and control to your Trial Master File. Stop by and say hello! #CenExel
Are you at the @DrugInformationAssociation #DIA2022 Global Annual Meeting in Chicago? Stop by booth 1506 or email [email protected] to schedule a meeting w/Tom Wardle, #CenExel CEO, and/or Casey Orvin, CenExel CCO, regarding CenExel’s capabilities to maximize clinical trials.
Together, our Business Development and leadership teams across our 19 Centers of Excellence throughout the US, we are able to serve some of the most diverse patient poulations in the country, resulting in the highest quality results. Come meet us at #DIA2022 in booth 1506.
Decentralized approaches facilitate participation by a more diverse patient population and could ease COVID-19-imposed difficulties for both patients and clinical investigators. Read more about our work with DTRA. #clinicaltrials
Decentralized approaches facilitate participation by a more diverse patient population and could ease COVID-19-imposed difficulties for both patients and clinical investigators. Read more about our work with DTRA. #clinicaltrials
Decentralized approaches facilitate participation by a more diverse patient population and could ease COVID-19-imposed difficulties for both patients and clinical investigators. Read more about our work with DTRA. #clinicaltrials
Decentralized approaches facilitate participation by a more diverse patient population and could ease COVID-19-imposed difficulties for both patients and clinical investigators. Read more about our work with DTRA. #clinicaltrials
Decentralized approaches facilitate participation by a more diverse patient population and could ease COVID-19-imposed difficulties for both patients and clinical investigators. Read more about our work with DTRA. #clinicaltrials
ForCare Clinical Research (“CenExel FCR”) Specializing in both chronic and acute Dermatology conditions, joins the CenExel Centers of Excellence Clinical Research Network.
Visit https://t.co/gIbeanvi05 to learn more.
#clinical#clinicaltrial#health#dermatology
The CDC states, 1 in 6 U.S. children aged 2–8 years (17.4%) had a diagnosed mental health disorder in 2020. Clinical trials help find new treatments for adolescents and adults alike. Click our bio link to learn about the research studies our Centers offer.
#clinicalreearch
Decentralized approaches facilitate participation by a more diverse patient population and could ease COVID-19-imposed difficulties for both patients and clinical investigators. Read more about our work with DTRA. #clinicaltrials